kubota glasses buy online- kubota glasses price: Japanese company launches “smart glasses”, promise every day of 1-hour testing can reduce access. This smart lens was developed by the Japanese company Kubota Pharmaceutical Holdings, effectively improving eyesight by eliminating the underlying cause of myopia.
kubota glasses price:
Ryo Kubota, an expert and CEO of ophthalmology – who develops smart glasses, has been studying the treatment of myopia for a long time.
The product principle is a way of projecting an image from the lens of this part to the wearer’s retina to correct the refractive error causing myopia. According to the company, if you wear the device for 60 to 90 minutes a day, you will improve myopia.
Through further clinical trials, they are trying to determine how long the effects will last after wearing them and how many days users have to wear the device to be able to permanently eliminate nearsightedness.
The biggest advantage of smart glasses is that you can restore your vision spontaneously without surgery.
President Ryo Kubota said he plans to start selling in the Asian market in the second half of this year and affirms it will especially help Asians who are very susceptible to myopia.
The current price has not been determined exactly, but Ryo Kubota said the minimum price is 100,000 円 (about 955.70 USD).
On the other hand, Kubota Pharmaceutical Holdings is developing a contact lens-style myopia correction device with similar effect behind smart glasses.
Currently, the company is considering whether to make the product available through local and online resellers.
kubota glasses buy online
This product nolonger to buy online on any platform!
Myopia, or nearsightedness, is a refractive vision disorder which causes blurred sight at a distance. It occurs when the length of the eye (known as axial length) is too great; myopia progresses as axial length increases with age, until the early 20s. Myopia currently affects 2.56 billion people worldwide and is projected to affect 3.4 billion people by 2030, if current trends remain unchanged(*1). Myopia increases the risk of developing sight-threatening diseases such as myopic maculopathy, retinal detachment, and glaucoma – making a measurable impact on society(*2). Today, children in East Asia (including Japan, China, Hong Kong, Taiwan, South Korea, and Singapore) develop myopia at a high rate; for example, 96.5% of 19-year-old males suffer from myopia in Seoul(*3). Myopia also affects over 40% of individuals over the age of 12 years in the U.S.(*4)
*1 Report of the Joint World Health Organization-Brien Holden Vision Institute, University of New South Wales, Sydney, Australia. The impact of myopia and high myopia. 16-18 March 2015.https://www.who.int/blindness/causes/MyopiaReportforWeb.pdf
*2 Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012 Nov;31(6):622-60
*3 Dolin E. The myopia boom. Nature 2015 Mar 19;519(7543):276-8
*4 Prevalence. International Myopia Institute. https://www.myopiainstitute.org/prevalence.html Accessed May 15, 2020.
Kubota Glass™ technology works to reduce the increase in axial length associated with myopia by projecting myopically-defocused virtual images generated using micro-LEDS on the peripheral visual field to actively stimulate the retina. Passive stimulation using myopic defocus is already in use in the US with a contact lens, “MiSight® 1 day” by CooperVision, which is U.S. Food and Drug Administration (FDA) approved to slow the progression of myopia. This product, which uses multifocal contact lens technology, passively stimulates the entire peripheral retina with light myopically defocused by the non-central power of the contact lens. Kubota Glass™ technology leverages nanotechnology in its electronic glasses-based device and seeks to reduce the progression of myopia by actively stimulating the retina for shorter periods while maintaining high-quality central vision and not affecting daily activities. The company is planning to submit the full data for scientific publication.
Kubota Vision conducted a clinical study in early 2020 with an electronic tabletop optical projection device (A) that embodied Kubota Glass™ technology. The company monitored the effect of the application of a myopically-defocused stimulus on the retina on axial length in 12 subjects of aged 21 to 32 years (7 Asian, 4 White, and 1 Hispanic subjects; 9 males and 3 females) with spherical refractive error of -3.5D〜0.0D. The results of the study demonstrated that axial length decreases with the application of projected myopically-defocused images in the test eye compared to the control eye, which has not been reported in the literature. The company also completed a successful proof-of-concept (POC) clinical study to validate the concept of a wearable myopia-control device based on Kubota Glass™ technology (B) in August 2020. Based on these results, the company has completed the first spectacle-style wearable prototype based on Kubota Glass™ technology (C).
Kubota Vision continues to advance its program. Further clinical studies will be conducted to verify the changes in axial length induced by myopically-defocused virtual image projection over a longer period of time. The company is also working on product design improvements and plans additional clinical studies for regulatory approvals.
Kubota Vision is also planning to use the Kubota Glass™ technology to develop smart contact lenses for the reduction of myopia progression. The development plan for a smart contact lens with Kubota Glass™ technology will be disclosed as the project progresses. The company envisions applications of Kubota Glass™ technology in augmented reality (AR) devices and virtual reality (VR) devices to protect children’s vision through myopia treatment.